Colgate-Palmolive (CL) Position Decreased by Evercore Wealth Management LLC

Evercore Wealth Management LLC reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 2.7% during the third quarter, HoldingsChannel reports. The firm owned 57,741 shares of the company’s stock after selling 1,630 shares during the period. Evercore Wealth Management LLC’s holdings in Colgate-Palmolive were worth $4,206,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Pacer Advisors Inc. increased its holdings in Colgate-Palmolive by 8.4% during the second quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after buying an additional 1,566 shares during the last quarter. Fiduciary Trust Co. increased its holdings in Colgate-Palmolive by 1.6% during the second quarter. Fiduciary Trust Co. now owns 170,818 shares of the company’s stock worth $12,663,000 after buying an additional 2,758 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in Colgate-Palmolive by 10.3% during the second quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock worth $83,914,000 after buying an additional 105,878 shares during the last quarter. Pensionfund DSM Netherlands purchased a new stake in Colgate-Palmolive during the third quarter worth about $4,225,000. Finally, Pacad Investment Ltd. purchased a new stake in Colgate-Palmolive during the second quarter worth about $549,000. 72.86% of the stock is currently owned by institutional investors.

CL has been the subject of several recent research reports. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Monday. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price for the company in a research note on Tuesday, December 19th. Deutsche Bank initiated coverage on shares of Colgate-Palmolive in a research note on Wednesday, December 13th. They issued a “hold” rating and a $75.00 target price for the company. Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Finally, KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and five have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $76.51.

In related news, Director Stephen I. Sadove sold 20,780 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the transaction, the director now owns 36,268 shares of the company’s stock, valued at $2,557,619.36. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CMO Mukul Deoras sold 7,500 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $73.28, for a total transaction of $549,600.00. Following the transaction, the chief marketing officer now directly owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 181,950 shares of company stock valued at $13,237,385. 1.02% of the stock is owned by corporate insiders.

Colgate-Palmolive (CL) opened at $74.62 on Tuesday. The company has a market cap of $65,520.00, a P/E ratio of 28.81, a P/E/G ratio of 3.15 and a beta of 0.81. Colgate-Palmolive has a 12 month low of $63.43 and a 12 month high of $77.27. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the consensus estimate of $0.73. The company had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. Colgate-Palmolive’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.73 earnings per share. equities analysts forecast that Colgate-Palmolive will post 2.88 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.

COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive (CL) Position Decreased by Evercore Wealth Management LLC” was first posted by BBNS and is the sole property of of BBNS. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://baseballnewssource.com/markets/colgate-palmolive-cl-position-decreased-by-evercore-wealth-management-llc/1838674.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with our FREE daily email newsletter.

 


Latest News

Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
Trade Rumor: Manny Machado Could Land With Yankees
Trade Rumor: Manny Machado Could Land With Yankees
Los Angeles Dodgers Acquire Scott Alexander as Part of Three Team Deal
Los Angeles Dodgers Acquire Scott Alexander as Part of Three Team Deal


Leave a Reply

 
© 2006-2018 BBNS.